(Q38352395)

2 September 2017

1 reference

title

Discrepancies between the effects of coronary reperfusion on survival and left ventricular function (English)

1 reference

2 September 2017

F Van de Werf

1

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 June 1989

1 reference

2 September 2017

1 reference

2 September 2017

volume

1

1 reference

2 September 2017

issue

8651

1 reference

2 September 2017

page(s)

1367-1369

1 reference

Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Global and regional left ventricular function and tomographic radionuclide perfusion: the Western Washington Intracoronary Streptokinase In Myocardial Infarction Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Ventricular function and infarct size: the Western Washington Intravenous Streptokinase in Myocardial Infarction Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992812-2

7 January 2021

10.1016/S0140-6736(89)92812-2

Identifiers

DOI

1 reference

2 September 2017

1 reference